677 related articles for article (PubMed ID: 22928729)
1. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
Inch J; Watson MC; Anakwe-Umeh S
Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
3. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
Inácio P; Airaksinen M; Cavaco A
Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study.
Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM
Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896
[TBL] [Abstract][Full Text] [Related]
5. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
[TBL] [Abstract][Full Text] [Related]
6. How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.
Hazell L; Cornelius V; Hannaford P; Shakir S; Avery AJ;
Drug Saf; 2013 Mar; 36(3):199-206. PubMed ID: 23444232
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol.
Dweik RA; Yaya S; Stacey D; Kohen D
Springerplus; 2016; 5():213. PubMed ID: 27026907
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
[TBL] [Abstract][Full Text] [Related]
9. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases.
Cliff-Eribo KO; Sammons H; Choonara I
Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085
[TBL] [Abstract][Full Text] [Related]
11. The value of patient reporting to the pharmacovigilance system: a systematic review.
Inácio P; Cavaco A; Airaksinen M
Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting patient reporting of adverse drug reactions: a systematic review.
Al Dweik R; Stacey D; Kohen D; Yaya S
Br J Clin Pharmacol; 2017 Apr; 83(4):875-883. PubMed ID: 27868226
[TBL] [Abstract][Full Text] [Related]
13. Patient Reporting in the EU: Analysis of EudraVigilance Data.
Banovac M; Candore G; Slattery J; Houÿez F; Haerry D; Genov G; Arlett P
Drug Saf; 2017 Jul; 40(7):629-645. PubMed ID: 28417320
[TBL] [Abstract][Full Text] [Related]
14. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
[TBL] [Abstract][Full Text] [Related]
15. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
[TBL] [Abstract][Full Text] [Related]
16. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.
Ribeiro-Vaz I; Santos C; da Costa-Pereira A; Cruz-Correia R
Drug Saf; 2012 May; 35(5):387-94. PubMed ID: 22468615
[TBL] [Abstract][Full Text] [Related]
17. Experiences with adverse drug reaction reporting by patients: an 11-country survey.
van Hunsel F; Härmark L; Pal S; Olsson S; van Grootheest K
Drug Saf; 2012 Jan; 35(1):45-60. PubMed ID: 22149419
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reaction reporting by patients in the Netherlands: three years of experience.
de Langen J; van Hunsel F; Passier A; de Jong-van den Berg L; van Grootheest K
Drug Saf; 2008; 31(6):515-24. PubMed ID: 18484785
[TBL] [Abstract][Full Text] [Related]
19. Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.
de Vries ST; Denig P; Andrić A; Dimov Di Giusti M; Ptaszynska-Neophytou A; Härmark L; Mol PGM;
Drug Saf; 2021 Oct; 44(10):1073-1083. PubMed ID: 34368940
[TBL] [Abstract][Full Text] [Related]
20. Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.
van Hunsel F; Passier A; van Grootheest K
Br J Clin Pharmacol; 2009 May; 67(5):558-64. PubMed ID: 19552751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]